Patients News | pharmaphorum

News

DBV gets peanut allergy therapy programme back on track

Shares in DBV have shot up on phase 3 results that set up a US filing for its peanut allergy therapy. which could plug a looming hole in the market.

News

Acting CDC director and former tech investor Jim O'Neill

CDC signs off on advice ending universal hepatitis B jabs

Overturning decades of advice, the CDC has said it no longer recommends that all US newborns receive a hepatitis B vaccine.

News

Prof Jonathan Benger named as NICE's new CEO

Prof Jonathan Benger will take over from Dr Sam Roberts as CEO of UK reimbursement authority NICE later this week, at a critical time for the agency.

News

Kyverna rises on stiff person syndrome data

Kyverna hopes to file CAR-T therapy miv-cell for approval as the first therapy for stiff person syndrome, a rare and debilitating autoimmune disease.

News

J&J's run of talc lawsuit setbacks continues

A California jury has awarded $40m in damages to two women who sued Johnson & Johnson, claiming that its talc products caused ovarian cancer.

News

Raymond Chua of Singapore's Health Sciences Authority and Lawrence Tallon of the UK Medicines and Healthcare products Regulatory Agency.

UK teams up with Singapore on healthtech regulation

A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.

DBV gets peanut allergy therapy programme back on track

CDC signs off on advice ending universal hepatitis B jabs

Prof Jonathan Benger named as NICE's new CEO

Kyverna rises on stiff person syndrome data

J&J's run of talc lawsuit setbacks continues

UK teams up with Singapore on healthtech regulation

Lilly points to long-lasting weight loss with orforglipron

How to meet your physicians where they are online

News

Editor's Picks